| 摘要 |
FIELD: medicine. ^ SUBSTANCE: substance of invention includes application of ligand associated with carrier, where ligand is protein FasL, or Fas leukocyte receptor-directed antibody, to reduce leukocyte activity for extracorporal application. Besides, this invention provides method of leukocyte activity reduction my means of specified module. ^ EFFECT: damaging action of associated activated leukocytes is inhibited by inactivation module within minutes. ^ 9 cl, 1 ex, 1 tbl, 1 dwg |
